GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (NYSE:INSP) » Definitions » Beneish M-Score

INSP (Inspire Medical Systems) Beneish M-Score : -0.09 (As of Dec. 13, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Inspire Medical Systems Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.09 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Inspire Medical Systems's Beneish M-Score or its related term are showing as below:

INSP' s Beneish M-Score Range Over the Past 10 Years
Min: -2.84   Med: -2.12   Max: 31.37
Current: -0.09

During the past 9 years, the highest Beneish M-Score of Inspire Medical Systems was 31.37. The lowest was -2.84. And the median was -2.12.


Inspire Medical Systems Beneish M-Score Historical Data

The historical data trend for Inspire Medical Systems's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems Beneish M-Score Chart

Inspire Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only - -2.13 16.50 -2.26 -2.12

Inspire Medical Systems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.43 -2.12 -1.73 -1.62 -0.09

Competitive Comparison of Inspire Medical Systems's Beneish M-Score

For the Medical Devices subindustry, Inspire Medical Systems's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspire Medical Systems's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's Beneish M-Score falls into.



Inspire Medical Systems Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Inspire Medical Systems for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9477+0.528 * 0.992+0.404 * 6.8572+0.892 * 1.3252+0.115 * 0.8637
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9144+4.679 * -0.056871-0.327 * 0.8396
=-0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was $89.7 Mil.
Revenue was 203.191 + 195.885 + 164.01 + 192.508 = $755.6 Mil.
Gross Profit was 170.793 + 166.042 + 139.253 + 164.454 = $640.5 Mil.
Total Current Assets was $582.5 Mil.
Total Assets was $796.2 Mil.
Property, Plant and Equipment(Net PPE) was $89.3 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.9 Mil.
Selling, General, & Admin. Expense(SGA) was $512.2 Mil.
Total Current Liabilities was $74.3 Mil.
Long-Term Debt & Capital Lease Obligation was $25.2 Mil.
Net Income was 18.497 + 9.793 + -10.005 + 14.763 = $33.0 Mil.
Non Operating Income was 0.118 + -0.135 + -0.06 + 0.073 = $-0.0 Mil.
Cash Flow from Operations was 52.283 + -0.078 + 8.86 + 17.267 = $78.3 Mil.
Total Receivables was $71.5 Mil.
Revenue was 153.302 + 151.092 + 127.897 + 137.9 = $570.2 Mil.
Gross Profit was 128.92 + 126.84 + 108.009 + 115.748 = $479.5 Mil.
Total Current Assets was $569.6 Mil.
Total Assets was $639.5 Mil.
Property, Plant and Equipment(Net PPE) was $55.3 Mil.
Depreciation, Depletion and Amortization(DDA) was $2.6 Mil.
Selling, General, & Admin. Expense(SGA) was $422.7 Mil.
Total Current Liabilities was $70.0 Mil.
Long-Term Debt & Capital Lease Obligation was $25.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(89.743 / 755.594) / (71.46 / 570.191)
=0.118771 / 0.125326
=0.9477

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(479.517 / 570.191) / (640.542 / 755.594)
=0.840976 / 0.847733
=0.992

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (582.52 + 89.258) / 796.194) / (1 - (569.591 + 55.33) / 639.494)
=0.156263 / 0.022788
=6.8572

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=755.594 / 570.191
=1.3252

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.598 / (2.598 + 55.33)) / (4.889 / (4.889 + 89.258))
=0.044849 / 0.051929
=0.8637

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(512.202 / 755.594) / (422.688 / 570.191)
=0.67788 / 0.741309
=0.9144

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((25.218 + 74.264) / 796.194) / ((25.173 + 69.995) / 639.494)
=0.124947 / 0.148818
=0.8396

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(33.048 - -0.004 - 78.332) / 796.194
=-0.056871

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Inspire Medical Systems has a M-score of -0.09 signals that the company is likely to be a manipulator.


Inspire Medical Systems Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspire Medical Systems Business Description

Traded in Other Exchanges
Address
5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Executives
John Rondoni officer: Chief Technology Officer C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Shawn Mccormick director 9600-54TH AVENUE NORTH, SUITE 100, PLYMOUTH MN 55441
Randy Ban officer: Senior VP. & Sales & Marketing C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Richard Buchholz officer: Chief Financial Officer C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Timothy P. Herbert director, 10 percent owner, officer: CEO and President C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Jerry C Griffin director 887L INDUSTRIAL ROAD, SAN CARLOS CA 94070
Charisse Y Sparks director C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Carlton Weatherby officer: Chief Strategy Officer C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Steven Jandrich officer: Chief Comp Off & VP, Human Res C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Philip Ebeling officer: Chief Operating Officer INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416
Marilyn C Nelson director C/O EXXON MOBIL CORP, 5959 LAS COLINAS BLVD., IRVING TX 75039-2298
Cynthia Burks director C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Georgia Melenikiotou director C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BOULEVARD, SUITE 1600, GOLDEN VALLEY MN 55416
Bryan K Phillips officer: See Remarks 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Shelley G. Broader director 880 CARILLON PARKWAY, ST. PETERSBURG FL 33702